NO993738D0 - 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia - Google Patents
2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemiaInfo
- Publication number
- NO993738D0 NO993738D0 NO993738A NO993738A NO993738D0 NO 993738 D0 NO993738 D0 NO 993738D0 NO 993738 A NO993738 A NO 993738A NO 993738 A NO993738 A NO 993738A NO 993738 D0 NO993738 D0 NO 993738D0
- Authority
- NO
- Norway
- Prior art keywords
- lipoproteinemia
- arteriosclerosis
- hyper
- amino
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19704243A DE19704243A1 (en) | 1997-02-05 | 1997-02-05 | New 2-amino-substituted pyridines |
PCT/EP1998/000362 WO1998034920A1 (en) | 1997-02-05 | 1998-01-23 | 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993738D0 true NO993738D0 (en) | 1999-08-02 |
NO993738L NO993738L (en) | 1999-09-17 |
Family
ID=7819326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993738A NO993738L (en) | 1997-02-05 | 1999-08-02 | 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0973744A1 (en) |
JP (1) | JP2001510478A (en) |
KR (1) | KR20000070756A (en) |
CN (1) | CN1252057A (en) |
AU (1) | AU730109B2 (en) |
BG (1) | BG103631A (en) |
BR (1) | BR9807181A (en) |
CA (1) | CA2279636A1 (en) |
CZ (1) | CZ279299A3 (en) |
DE (1) | DE19704243A1 (en) |
HU (1) | HUP0001022A2 (en) |
ID (1) | ID24208A (en) |
IL (1) | IL131127A0 (en) |
NO (1) | NO993738L (en) |
NZ (1) | NZ337011A (en) |
PL (1) | PL334899A1 (en) |
SK (1) | SK104099A3 (en) |
TR (1) | TR199901857T2 (en) |
WO (1) | WO1998034920A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2275091A1 (en) | 2001-06-22 | 2011-01-19 | Pfizer Products Inc. | Pharmaceutical compositions comprising adsorbates of an amorphous drug |
ATE444060T1 (en) | 2001-06-22 | 2009-10-15 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS CONTAINING DISPERSIONS OF MEDICINAL SUBSTANCES AND NEUTRAL POLYMERS |
DE60320940D1 (en) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF ACTIVE SUBSTANCES AND LIPOPHILIC MICROPHASE-BASED MATERIALS |
MXPA05009976A (en) | 2003-03-17 | 2005-11-04 | Japan Tobacco Inc | Method for increasing the oral bioavailability of s-`2- (``1-(2- ethylbutyl) cyclohexyl! carbonyl! amino) phenyl!-2- methylpropanethioate. |
CL2004001884A1 (en) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS. |
ATE540671T1 (en) | 2003-08-04 | 2012-01-15 | Bend Res Inc | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DRUG ADSORBATES AND LIPOPHILIC MICROPHASE-FORMING MATERIALS |
JP4536061B2 (en) | 2003-09-26 | 2010-09-01 | 日本たばこ産業株式会社 | Method for inhibiting remnant lipoprotein production |
DOP2005000123A (en) * | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | CETP INHIBITORS |
WO2006032987A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Indoline compounds and their use in the treatment of arteriosclerosis |
EP1844078B1 (en) | 2005-02-03 | 2016-09-28 | Bend Research, Inc | Pharmaceutical compositions with enhanced performance |
US20100113473A1 (en) | 2008-10-30 | 2010-05-06 | Player Mark R | Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
-
1997
- 1997-02-05 DE DE19704243A patent/DE19704243A1/en not_active Withdrawn
-
1998
- 1998-01-23 WO PCT/EP1998/000362 patent/WO1998034920A1/en not_active Application Discontinuation
- 1998-01-23 PL PL98334899A patent/PL334899A1/en unknown
- 1998-01-23 ID IDW990821D patent/ID24208A/en unknown
- 1998-01-23 JP JP53369198A patent/JP2001510478A/en active Pending
- 1998-01-23 TR TR1999/01857T patent/TR199901857T2/en unknown
- 1998-01-23 IL IL13112798A patent/IL131127A0/en unknown
- 1998-01-23 CA CA002279636A patent/CA2279636A1/en not_active Abandoned
- 1998-01-23 CN CN98803916A patent/CN1252057A/en active Pending
- 1998-01-23 SK SK1040-99A patent/SK104099A3/en unknown
- 1998-01-23 EP EP98904126A patent/EP0973744A1/en not_active Ceased
- 1998-01-23 CZ CZ992792A patent/CZ279299A3/en unknown
- 1998-01-23 BR BR9807181-5A patent/BR9807181A/en not_active IP Right Cessation
- 1998-01-23 KR KR1019997007015A patent/KR20000070756A/en not_active Application Discontinuation
- 1998-01-23 AU AU62123/98A patent/AU730109B2/en not_active Ceased
- 1998-01-23 NZ NZ337011A patent/NZ337011A/en unknown
- 1998-01-23 HU HU0001022A patent/HUP0001022A2/en unknown
-
1999
- 1999-08-02 NO NO993738A patent/NO993738L/en not_active Application Discontinuation
- 1999-08-03 BG BG103631A patent/BG103631A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2279636A1 (en) | 1998-08-13 |
TR199901857T2 (en) | 1999-10-21 |
NO993738L (en) | 1999-09-17 |
AU6212398A (en) | 1998-08-26 |
EP0973744A1 (en) | 2000-01-26 |
CN1252057A (en) | 2000-05-03 |
AU730109B2 (en) | 2001-02-22 |
HUP0001022A2 (en) | 2000-09-28 |
IL131127A0 (en) | 2001-01-28 |
NZ337011A (en) | 2001-04-27 |
BG103631A (en) | 2000-11-30 |
KR20000070756A (en) | 2000-11-25 |
WO1998034920A1 (en) | 1998-08-13 |
JP2001510478A (en) | 2001-07-31 |
DE19704243A1 (en) | 1998-08-06 |
BR9807181A (en) | 2000-01-25 |
ID24208A (en) | 2000-07-13 |
SK104099A3 (en) | 2000-01-18 |
PL334899A1 (en) | 2000-03-27 |
CZ279299A3 (en) | 1999-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970373D0 (en) | Benzoxazoles and pyridine derivatives useful in the treatment of type II diabetes | |
DE60136736D1 (en) | Pyrimidine derivatives and their use in the treatment of atherosclerosis | |
AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
DE69925186D1 (en) | Addition of glucosaminoglycans and their precursors in food | |
NO20002846L (en) | Inhalation device and method of the same | |
NO2008012I2 (en) | Dabigatran ethoxylate and its salts - especially dabigatran ethoxylate mesylate | |
NO20001323D0 (en) | Dipeptide-apoptosis inhibitors and their use | |
NO993738D0 (en) | 2-amino-substituted pyridines which can be used in the treatment of arteriosclerosis and hyper-lipoproteinemia | |
NO983576D0 (en) | Well treatment fluids and methods | |
FI980246A0 (en) | Method of using the kettle and kettle | |
DK91793A (en) | Method of surface treatment, means of application and its use | |
DK0767666T3 (en) | Methods and Preparations Useful in Prophylaxis and Treatment of Endotoxin-Related Conditions | |
NO20001412D0 (en) | Compositions and Methods in the Treatment of Respiratory Disorders | |
NO991160D0 (en) | Sulfate-containing polysaccharides and their applications in medical treatment | |
NO972426D0 (en) | Method for the use of triarylethylene derivatives in the treatment and prevention of osteoporosis | |
NO20020031D0 (en) | Dihydrobenzodiazepines and their use in the treatment of dyslipidemia | |
DK0898566T3 (en) | Substituted benzylamines and their use in the treatment of depression | |
NO20011606L (en) | Process for the cleaning and decontamination of polyesters | |
NO985806D0 (en) | Chitinase Materials and Methods | |
NO20001758D0 (en) | Methods and compositions for the treatment of arthritis | |
NO993102D0 (en) | Chip card and method of using the chip card | |
AU7688998A (en) | Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema | |
NO992310D0 (en) | Inhibitors and their use in oils | |
FI972468A (en) | Locks that can be opened and closed from opposite sides | |
NO961733D0 (en) | Procedure for disinfection and drying |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |